Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRALINE: Pemafibrate + Rosuvastatin vs Rosuvastatin on Coronary Lipid Core Plaques
jRCT1051190122Recruiting
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of pemafibrate in coronary arteriosclerosis, acute ST-segment elevation myocardial infarction (STEMI), Non-ST-segment elevation myocardial infarction (NSTEMI) and 2 more (2 arms). Primary endpoint: Change in maxLCBI(4mm). Started Mar 2020; status: recruiting.
02
Drugs
pemafibrate
03
Conditions
coronary arteriosclerosisacute ST-segment elevation myocardial infarction (STEMI)Non-ST-segment elevation myocardial infarction (NSTEMI)unstable anginastable angina
Beyond the preview
Go deeper on jRCT1051190122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051190122.